• Cardiac Biomarkers in Baboon Epilepsy: QT Interval & HRV Ins

  2026-06-26

  This study investigates cardiac biomarkers—specifically QT interval prolongation and heart rate variability (HRV)—in a pedigreed baboon model of idiopathic generalized epilepsy. The findings demonstrate significant QT prolongation and reduced HRV in epileptic baboons, providing translational insights into SUDEP risk assessment and highlighting new avenues for preclinical epilepsy research.

• AM251 and CB1 Signaling: Strategic Advances in Translational

  2026-06-26

  Explore the mechanistic and translational landscape of AM251, a potent CB1 receptor antagonist, and its implications for cannabinoid receptor research, neuropharmacology, and obesity treatment. This thought-leadership article integrates latest mechanistic insights, experimental strategies, and strategic guidance for bench-to-bedside translation.

• Acridine Orange hydrochloride: Practical Guide for Cell-Base

  2026-06-25

  Acridine Orange hydrochloride enables precise, differential staining of DNA and RNA for cell cycle analysis, apoptosis detection, and flow cytofluorometric nucleic acid assays. It is best used in validated cytochemical protocols, with careful attention to solution stability and nucleic acid specificity. This reagent is not recommended for non-nucleic acid targets or applications requiring long-term storage of working solutions.

• Environmental and Experimental Impacts of (S)-(+)-Ibuprofen

  2026-06-25

  (S)-(+)-Ibuprofen stands out as a precise COX inhibitor for inflammation pathway research, but its biochemical potency is matched by ecological implications. This article uniquely explores both its advanced experimental applications and emerging environmental concerns, offering new insights for researchers and environmental scientists.

• Syringin in RCC Research: Deep Mechanistic Insights & Protoc

  2026-06-24

  Explore the multifaceted mechanisms and experimental integration of Syringin, a bioactive natural product, for advanced renal cell carcinoma research. This in-depth analysis uniquely links Syringin's molecular action with practical assay decisions and highlights its role in overcoming sunitinib resistance.

• LAG-3/TCR Proximity: Mechanisms of T Cell Suppression in Aut

  2026-06-23

  Du et al. (2025) uncover that the physical proximity of LAG-3 to the T cell receptor, rather than its interaction with CD4, is essential for suppressing T cell activation and autoimmunity. Their mechanistic and translational findings provide new targets for selective immune modulation and inform advanced workflows in T cell research.

• Strategic Protease Inhibition: Mechanisms to Translation

  2026-06-23

  This thought-leadership article explores how the mechanistic depth of protease biology, exemplified by recent research in plant and human systems, directly informs strategic decision-making in translational research. Leveraging the DiscoveryProbe™ Protease Inhibitor Library, we examine pathways for experimental optimization, high-throughput screening innovation, and the evolving clinical relevance of protease inhibition. The discussion offers protocol guidance, competitive context, and a forward-looking vision for next-generation therapeutic discovery.

• Annexin V-Cy5/DAPI Apoptosis Kit: Precision Apoptosis Detect

  2026-06-22

  The Annexin V-Cy5/DAPI Apoptosis Kit enables rapid, sensitive, and specific detection of apoptosis and necrosis by combining phosphatidylserine binding with nuclear staining. This apoptosis detection kit distinguishes early and late cell death events in 10–20 minutes, supporting robust research in programmed cell death and drug responses.

• Neomycin Sulfate: Beyond Antibiotics—A Molecular Modulator

  2026-06-22

  Explore Neomycin sulfate, a leading aminoglycoside antibiotic, as a versatile molecular tool for nucleic acid and ion channel research. Discover unique mechanistic insights and advanced applications not covered by existing literature.

• JSH-23: Potent NF-κB Inhibitor for Inflammation Research

  2026-06-21

  JSH-23 is a well-characterized small molecule NF-κB inhibitor that blocks p65 nuclear translocation, suppressing pro-inflammatory cytokine expression. Its robust solubility and specificity make it valuable for inflammation research and NF-κB signaling pathway studies. APExBIO provides JSH-23 (B1645) with validated protocols for reproducible experimental results.

• Revisiting Sumatriptan Metabolism: New Insights Into CYP and

  2026-06-20

  The reference study challenges the conventional view that sumatriptan metabolism is dominated by MAO A-mediated deamination by demonstrating significant involvement of cytochrome P450 enzymes in N-demethylation. This nuanced understanding refines the metabolic map of sumatriptan and has broader implications for drug interaction studies and neuroactive compound research.

• Amyloid Beta-peptide (25-35): Protocols for Neurotoxicity Mo

  2026-06-19

  Amyloid Beta-peptide (25-35) (Aβ25-35) is the gold-standard tool for modeling Alzheimer's disease neurotoxicity and microglial polarization in vitro. This guide demystifies advanced workflows, troubleshooting, and protocol optimization using APExBIO’s validated peptide, enabling reproducible and translationally relevant neurodegenerative research.

• Sinapine Disrupts Gαq-PLCβ3 to Ameliorate Cardiovascular Dis

  2026-06-19

  This study reveals that sinapine selectively targets the EF hand domain of PLCβ3, disrupting Gαq-PLCβ3 interaction and alleviating aldosteronism and hypertension in animal models. The findings provide a precise molecular intervention point within the RAAS pathway, with greater selectivity and fewer side effect risks compared to traditional pan-PLC or Gαq inhibitors.

• 2-APB: Precision Control of Calcium Signaling in Cell Fate S

  2026-06-18

  Unlock the full experimental power of 2-APB (2-aminoethoxydiphenyl borate) for dissecting ER-Ca2+ signaling and programmed cell death. This guide delivers advanced protocols, troubleshooting strategies, and practical insights from the latest Bombyx mori research.

• Lanabecestat (AZD3293): Advancing Amyloid-Beta Research Work

  2026-06-18

  Lanabecestat (AZD3293) from APExBIO delivers potent, brain-penetrant BACE1 inhibition—enabling precise modulation of amyloid-beta levels in Alzheimer’s disease models. This article translates the latest reference findings into actionable protocols, troubleshooting strategies, and workflow optimizations for reproducible, synaptic-sparing research.

16247 records 1/1084 page Next 12345 下5页 Last page